title: Vesicoureteral reflux: the RIVUR study and the way forward.
authors: Saul P
authors: SP
authors: Greenfield
authors: Russell W
authors: RW
authors: Chesney
authors: Myra
authors: M
authors: Carpenter
authors: Marva
authors: M
authors: Moxey-Mims
authors: Leroy
authors: L
authors: Nyberg
authors: Alejandro
authors: A
authors: Hoberman
authors: Ron
authors: R
authors: Keren
authors: Ranjiv
authors: R
authors: Matthews
authors: Tej
authors: T
authors: Mattoo
mesh_terms: D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D002648:Child; D006801:Humans; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D014718:Vesico-Ureteral Reflux / Q000150:complications* / Q000175:diagnosis / Q000628:therapy
chemical_list: D000892:Anti-Infective Agents, Urinary; D015662:Trimethoprim, Sulfamethoxazole Drug Combination